Cargando…

Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism

OBJECTIVES: To investigate the safety and feasibility of gasless axillary parathyroid surgery in the treatment of primary hyperparathyroidism. METHODS: A total of 12 patients who received gasless axillary parathyroidectomy (endoscope group) and 14 patients who received traditional open parathyroidec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wan-Chen, Lu, Dong-Ning, Xu, Jia-Jie, Guo, Hai-Wei, Ge, Ming-Hua, Zheng, Chuan-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632965/
https://www.ncbi.nlm.nih.gov/pubmed/36338640
http://dx.doi.org/10.3389/fsurg.2022.962463
_version_ 1784824156776300544
author Zhang, Wan-Chen
Lu, Dong-Ning
Xu, Jia-Jie
Guo, Hai-Wei
Ge, Ming-Hua
Zheng, Chuan-Ming
author_facet Zhang, Wan-Chen
Lu, Dong-Ning
Xu, Jia-Jie
Guo, Hai-Wei
Ge, Ming-Hua
Zheng, Chuan-Ming
author_sort Zhang, Wan-Chen
collection PubMed
description OBJECTIVES: To investigate the safety and feasibility of gasless axillary parathyroid surgery in the treatment of primary hyperparathyroidism. METHODS: A total of 12 patients who received gasless axillary parathyroidectomy (endoscope group) and 14 patients who received traditional open parathyroidectomy (open group) from January 2019 to April 2022 were screened and included. The differences in baseline characteristics, surgical efficiency, incidence rate of complications, changes in biochemical indicators, and incision satisfaction between the two groups were analyzed and compared. RESULTS: The proportion of young patients was higher in the endoscopic group than in the open group, and the difference was statistically significant [(41.33 ± 13.65) years vs. (58.00 ± 9.44) years, P < 0.01]. The differences in operation time, intra-operative blood loss, post-operative drainage volume, hospital stay, and surgical efficiency between the two groups yielded no statistical significance (P > 0.05). Patients in the open group had more significant neck pain 3 days after surgery (P = 0.046), but the degree of pain 3 months after surgery was the same in the 2 groups (P = 0.432). Evaluation of post-operative mature stage scar and incision satisfaction regarding aesthetics in the endoscope group were significantly superior to that in the open group [(1.92 ± 0.92) points vs. (0.92 ± 1.00) points, P = 0.017 and (1.57 ± 0.51) points vs. (1.00 ± 0.013) points, P = 0.013, respectively]. No statistical significance was found in terms of incidence rate of post-operative fever (P > 0.05). No temporary recurrent laryngeal nerve injury, post-operative bleeding, incision hematoma infection, or other complications were observed. Comparing the two groups, the extent of the level decrease of PTH was similar to that of serum calcium and phosphorus (P < 0.05), where most patients experienced transient hypocalcemia after operation yielding no significant difference in incidence (P = 0.225). During a follow-up period of 3 to 36 months, a total of 1 patient in the open group experienced recurrence at 10 months after surgery and was treated non-surgically. CONCLUSION: Gasless axillary approach to parathyroid surgery for primary hyperparathyroidism possesses good safety and patient satisfaction in terms of aesthetics.
format Online
Article
Text
id pubmed-9632965
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96329652022-11-04 Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism Zhang, Wan-Chen Lu, Dong-Ning Xu, Jia-Jie Guo, Hai-Wei Ge, Ming-Hua Zheng, Chuan-Ming Front Surg Surgery OBJECTIVES: To investigate the safety and feasibility of gasless axillary parathyroid surgery in the treatment of primary hyperparathyroidism. METHODS: A total of 12 patients who received gasless axillary parathyroidectomy (endoscope group) and 14 patients who received traditional open parathyroidectomy (open group) from January 2019 to April 2022 were screened and included. The differences in baseline characteristics, surgical efficiency, incidence rate of complications, changes in biochemical indicators, and incision satisfaction between the two groups were analyzed and compared. RESULTS: The proportion of young patients was higher in the endoscopic group than in the open group, and the difference was statistically significant [(41.33 ± 13.65) years vs. (58.00 ± 9.44) years, P < 0.01]. The differences in operation time, intra-operative blood loss, post-operative drainage volume, hospital stay, and surgical efficiency between the two groups yielded no statistical significance (P > 0.05). Patients in the open group had more significant neck pain 3 days after surgery (P = 0.046), but the degree of pain 3 months after surgery was the same in the 2 groups (P = 0.432). Evaluation of post-operative mature stage scar and incision satisfaction regarding aesthetics in the endoscope group were significantly superior to that in the open group [(1.92 ± 0.92) points vs. (0.92 ± 1.00) points, P = 0.017 and (1.57 ± 0.51) points vs. (1.00 ± 0.013) points, P = 0.013, respectively]. No statistical significance was found in terms of incidence rate of post-operative fever (P > 0.05). No temporary recurrent laryngeal nerve injury, post-operative bleeding, incision hematoma infection, or other complications were observed. Comparing the two groups, the extent of the level decrease of PTH was similar to that of serum calcium and phosphorus (P < 0.05), where most patients experienced transient hypocalcemia after operation yielding no significant difference in incidence (P = 0.225). During a follow-up period of 3 to 36 months, a total of 1 patient in the open group experienced recurrence at 10 months after surgery and was treated non-surgically. CONCLUSION: Gasless axillary approach to parathyroid surgery for primary hyperparathyroidism possesses good safety and patient satisfaction in terms of aesthetics. Frontiers Media S.A. 2022-09-22 /pmc/articles/PMC9632965/ /pubmed/36338640 http://dx.doi.org/10.3389/fsurg.2022.962463 Text en © 2022 Zhang, Lu, Xu, Guo, Ge and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Zhang, Wan-Chen
Lu, Dong-Ning
Xu, Jia-Jie
Guo, Hai-Wei
Ge, Ming-Hua
Zheng, Chuan-Ming
Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title_full Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title_fullStr Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title_full_unstemmed Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title_short Clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
title_sort clinical application of endoscopic surgery using a gasless unilateral transaxillary approach in the treatment of primary hyperparathyroidism
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632965/
https://www.ncbi.nlm.nih.gov/pubmed/36338640
http://dx.doi.org/10.3389/fsurg.2022.962463
work_keys_str_mv AT zhangwanchen clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism
AT ludongning clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism
AT xujiajie clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism
AT guohaiwei clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism
AT geminghua clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism
AT zhengchuanming clinicalapplicationofendoscopicsurgeryusingagaslessunilateraltransaxillaryapproachinthetreatmentofprimaryhyperparathyroidism